ELISSA REED: Open Payments
NPI 1588141808 · DAYTON, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,434 in 135 payments from 32 companies in 2025. Trend: 2023 $2,890 · 2024 $3,492 · 2025 $2,434
Food & beverage: $2,434
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $352 |
| AstraZeneca Pharmaceuticals LP | 11 | $311 |
| ABBVIE INC. | 19 | $282 |
| Lilly USA, LLC | 15 | $241 |
| Almatica Pharma LLC | 5 | $108 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $100 |
| Astellas Pharma US Inc | 4 | $87 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $82 |
| Exact Sciences Corporation | 4 | $79 |
| Axsome Therapeutics, Inc. | 3 | $73 |
Products named: JARDIANCE, BREZTRI, Wegovy, VRAYLAR, MOUNJARO, LOREEV XR, XIFAXAN, Ozempic.
Industry payments across OH — which companies pay providers there.
